NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 10.16% |
BSX | Boston Scientific Corp | Healthcare | Medical Devices | 7.66% |
ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.90% |
ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.83% |
AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 5.64% |
TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 4.61% |
ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 4.32% |
PODD | Insulet Corporation | Healthcare | Medical Devices | 4.05% |
ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.66% |
A | Agilent Technologies Inc | Healthcare | Diagnostics & Research | 3.56% |
MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.55% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.23% |
7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 3.15% |
LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.12% |
COR | Cencora Inc. | Healthcare | Medical Distribution | 3.07% |
VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.75% |
NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.69% |
BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.58% |
BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |